Serum chromium, glycosylated hemoglobin level and body mass index among control and uncontrol sudanese patients with type II diabetes mellitus: Correlation study

Nassr Eldin M. A.  shrif; Ahmed Mohamed Ahmed  Dawood; Abdelmahmoud Mokhtar  Bashir; Hassan Mohammed Khair  Ibrahim; Abd Elgadir A  Altoum

doi:10.30574/gscbps.2021.16.2.0219

Authors

Nassr Eldin M. A. shrif Clinical chemistry - Al-Zaiem Al-Azhari University, Sudan.
Ahmed Mohamed Ahmed Dawood Clinical chemistry - Al-Zaiem Al-Azhari University, Sudan.
Abdelmahmoud Mokhtar Bashir Department of Hematology, Faculty of Medical Laboratory Sciences, Sudan University of Science and Technology, Khartoum, Sudan.
Hassan Mohammed Khair Ibrahim Medical Laboratory Sciences, college of health sciences, Gulf Medical University, AL JURF - Ajman - United Arab Emirates.
Abd Elgadir A Altoum Clinical chemistry - Al-Zaiem Al-Azhari University, Sudan.

DOI:

https://doi.org/10.30574/gscbps.2021.16.2.0219

Keywords:

Type II diabetes, Chromium, Glycosylated Hemoglobin, Body Mass Index

Abstract

Background: Chromium is an essential micronutrient which is required for the normal functioning of insulin and regulation of blood sugar levels. It acts as a vital antioxidant for maintaining insulin homeostasis. In diabetes mellitus, the free radical production is increased and levels of antioxidants like chromium, vanadium, selenium and manganese are reduced.

Aim: To study the level of serum chromium level in patients with type 2 diabetes mellitus and its association with glycemic control.

Materials and Methods: One hundred and twenty individuals were enrolled in this study, classified into 60 type II diabetes mellitus (type II DM) patients and 60 apparently health as control group. Serum chromium and Glycosylated Hemoglobin (HbA1c) level were measured using atomic absorption spectrometry and Ichroma. Results: The results showed significant decrease in serum chromium level in type II DM patients (0.0151±0.005) when compared with healthy group (0.122±0.691) with p-value (0.002). In addition to that there was significant decrease in mean concentration of serum chromium level in controlled diabetic patients (0.0206± 0.003) when compared with uncontrolled diabetic patients (0.0120±0.002) with P-value (0.04).Also there was significant positive correlation between chromium level and Body Mass Index (BMI) (R-value 0.450, P-value 0.014), and significant negative correlation between chromium level and age (R-value- 0.660, P-value 0.011) , a significant strong negative correlation between chromium level and HbA1c (R-value -0.843, P-value 0.0260).

Conclusion: The study concluded that, serum chromium level is significantly decrease in type II DM.

Metrics

Metrics Loading ...

References

Lewicki S, Zdanowski R, Krzyzowska M, Lewicka A, Debski B, Niemcewicz M, et al. The role of Chromium III in the organism and its possible use in diabetes and obesity treatment. Ann AgriEnv Med. 2014; 2: 331–35.

Cefalu WT, Hu FB. Role of Chromium in Human Health and in Diabetes.Diabetes Care. 2004; 27(11): 2741-51.

Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009; 32(7): 1335–43.

Davis S, McLaren Howard J, Hunnisett A, Howard M. Age related decrease in Chromium levels in 51,665 hair, sweat and serum samples from 40782 patients–implications for prevention of cardiovascular disease and type 2 diabetes. Metabolism. 2019; 46(5): 469-73.

Ngala RA, Awe MA, Nsiah P. The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study. PLoS One. 5 Jul 2018; 13(7): e0197977.

Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MFR, et al. Ethnic differences in C-reactive protein concentrations. ClinChem. 2008; 54:1027–1037.

Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, et al. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat Metabolism. 2007; 56: 1233–1240.

Rajendran K, Manikandan S, Nair LD, Karuthodiyil R, Vijayarajan N, Gnanasekar R, Kapil VV, Mohamed AS. Serum Chromium Levels in Type 2 Diabetic Patients and Its Association with Glycaemic Control. J Clin Diagn Res. Nov 2015; 9(11): OC05-8.

Nsonwu AC, Usoro CAO, Etukudo MH, Usoro IN. Influence of Age, Gender and Duration of Diabetes on Serum and Urine Levels of Zinc, Magnesium, Selenium and Chromium in Type 2 Diabetics in Calabar, Nigeria. Turk J Biochem.2006; 31(3): 107-14.

Doddigarla Z, Parwez I, Ahmad J. Correlation of serum chromium, zinc, magnesium and SOD levels with HbA1c in type 2 diabetes: A cross sectional analysis. Diabetes Metab Syndr. Jan-Mar 2016; 10(1 Suppl 1): S126-9.

Abd Elgadir A. Altoum et al. Status of some selected Trace Elements Levels and lipid profile in Ischemic heart disease patients with type 2 Diabetes Mellitus. International Journal of Pharmaceutical Research. Oct - Dec 2020; 12.

Mohamed H, Sadik I, Eltom A, Osman A, Babker A. A Study of Correlation of Serum Chromium Level with Glycosylated Haemoglobin (HbA1c), Total Cholesterol and Triglycerides, among Type 2 Diabetes Patients. Open Journal of Blood Diseases. Mar 2019; 9(1): 1-8.

Eva H, Akter QS, Alam MK. Relationship between Glycemic Status and Serum Chromium Level with Type 2 Diabetes Mellitus. Mymensingh Med J. Jan 2020; 29(1): 183-186.